[First results of comprehensive genomic studies on solid tumours in National Institute of Oncology].

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

[First results of comprehensive genomic studies on solid tumours in National Institute of Oncology].

Magyar onkologia - 21 Mar 2025

Tóth Erika, Csernák Erzsébet, Kohánka Andrea, Báthory-Fülöp László, Butz Henriett, Patócs Attila, Pintér Tamás, Horváth Zsolt, Küronya Zsófia, Strausz Tamás, Adamik Imola, Melegh Zsombor

Abstract excerpt

AIMS: The Molecular Pathology Laboratory of the National Institute of Oncology has been performing comprehensive genomic studies (500-gene panel) since 2021. This paper summarizes our results obtained between 2022 and 2024, focusing on clinical requests, the histological type of cases studied and the potential therapeutic benefit of identified variants. METHODS: Comprehensive genomic profiling was performed using...

Read the complete abstract on PubMed

Topics

Humans
High-Throughput Nucleotide Sequencing
Female
Genomics
Mutation
Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Male

Sarcoma

Middle Aged

Adult

Genital Neoplasms, Female

Biomarkers, Tumor

Molecular Targeted Therapy

Source

Open in PubMed Open full text

Identifiers

PMID: 40117481
PMCID: PMC11929570

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 21 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[First results of comprehensive genomic studies on solid tumours in National Institute of Oncology].PMID 40117481Read ↗

Next-Generation Sequencing in Oncology-A Guiding Compass for Targeted Therapy and Emerging Applications.Semantic proximity Read ↗

A single-institution retrospective study of comprehensive genomic profiling tests based on C-CAT findings for advanced solid cancers.Semantic proximity Read ↗

Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic ArsenalSemantic proximity Read ↗

Clinical Utility of Large Next-Generation Sequencing Panel Across Diverse Tumour Types: A Single-Center Retrospective Analysis.Semantic proximity Read ↗

Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country.Semantic proximity Read ↗

Validation of a targeted sequencing panel with automatic analysis system for clinical decision support in cancer therapySemantic proximity Read ↗

Landscape of somatic alterations in large-scale solid tumors from an Asian populationSemantic proximity Read ↗

Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the "MOZART" prospective observational study.Semantic proximity Read ↗

Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.Semantic proximity Read ↗

Defining the clinical genomic landscape for real-world precision oncology.Semantic proximity Read ↗

First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy Opportunities.Semantic proximity Read ↗

Landscape of somatic alterations in large-scale solid tumors from an Asian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.